KDM5B and Cognitive impairment: Our results strongly suggest a gene dosage effect for KDM5B, where biallelic, near-complete LoF for KDM5B will lead to more severely impaired cognitive function as observed in patient cohorts, whereas HET KDM5B LoF will present with only moderate cognitive impairment that overlaps with the spectrum of cognitive function in the normal population.